ADVANCED BLADDER-CANCER - THE NEED TO IDENTIFY NEW AGENTS IN THE POST-M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) WORLD

被引：63

作者：

ROTH, BJ

BAJORIN, DF

机构：

[1] INDIANA UNIV,MED CTR,CTR CANC,DEPT MED,DIV HEMATOL ONCOL,INDIANAPOLIS,IN

[2] CORNELL UNIV,MED CTR,DEPT MED,NEW YORK,NY 10021

[3] MEM SLOAN KETTERING CANC CTR,DEPT MED,DIV SOLID TUMOR ONCOL,GENITOURINARY ONCOL SERV,NEW YORK,NY 10021

来源：

JOURNAL OF UROLOGY | 1995年 / 153卷 / 03期

关键词：

BLADDER NEOPLASMS; DRUG THERAPY;

D O I：

10.1016/S0022-5347(01)67598-0

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：894 / 900

页数：7

共 88 条

[1]

ABRATT R, 1993, P AN M AM SOC CLIN, V12, P338

[2] CARBOPLATIN AND 5-FLUOROURACIL IN POOR PERFORMANCE STATUS PATIENTS WITH ADVANCED UROTHELIAL CANCER [J].

ARENA, MG ;

STERNBERG, CN ;

ZEULI, M ;

DECARLI, P ;

CANCRINI, A ;

PANSADORO, V ;

CALABRESI, F .

ANNALS OF ONCOLOGY, 1993, 4 (03) :241-244

[3]

BELLMUNT J, 1993, P AM SOC CLIN ONCOL, V12, P237

[4] 2,4-DIAMINO-5-METHYL-6-[(3,4,5-TRIMETHOXYANILINO)METHYL]QUINAZOLINE (TMQ), A POTENT NON-CLASSICAL FOLATE ANTAGONIST INHIBITOR .1. EFFECT ON DIHYDROFOLATE-REDUCTASE AND GROWTH OF RODENT TUMORS INVITRO AND INVIVO [J].

BERTINO, JR ;

SAWICKI, WL ;

MOROSON, BA ;

CASHMORE, AR ;

ELSLAGER, EF .

BIOCHEMICAL PHARMACOLOGY, 1979, 28 (12) :1983-1987

[5]

BOCCARDO F, 1994, CANCER, V73, P1932, DOI 10.1002/1097-0142(19940401)73:7<1932::AID-CNCR2820730726>3.0.CO

[6]

2-Y

[7] CANCER STATISTICS, 1994 [J].

BORING, CC ;

SQUIRES, TS ;

TONG, T ;

MONTGOMERY, S .

CA-A CANCER JOURNAL FOR CLINICIANS, 1994, 44 (01) :7-26

[8] M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) FOR ADVANCED-CARCINOMA OF THE BLADDER - THE FRENCH FEDERATION OF CANCER CENTERS EXPERIENCE [J].

BOUTANLAROZE, A ;

MAHJOUBI, M ;

DROZ, JP ;

CHARROT, P ;

FARGEOT, P ;

KERBRAT, P ;

CATY, A ;

VOISIN, PM ;

SPIELMANN, M ;

REY, A ;

GIRAUD, B .

EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) :1690-1694

[9]

Carmichael J, 1993, P AN M AM SOC CLIN, V12, P64

[10] PHASE-II TRIAL OF GEMCITABINE (2,2'-DIFLUORODEOXYCYTIDINE) IN PATIENTS WITH ADENOCARCINOMA OF THE PANCREAS [J].

CASPER, ES ;

GREEN, MR ;

KELSEN, DP ;

HEELAN, RT ;

BROWN, TD ;

FLOMBAUM, CD ;

TROCHANOWSKI, B ;

TARASSOFF, PG .

INVESTIGATIONAL NEW DRUGS, 1994, 12 (01) :29-34

← 1 2 3 4 5 6 7 8 9 →